超敏感反应解释了结合化疗的好处,尽管药物对抗性

相关实验视频

Updated: Jun 29, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Sarah C Patterson¹, Amy E Pomeroy¹, Adam C Palmer¹

¹Department of Pharmacology, Computational Medicine Program, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Molecular cancer therapeutics

|March 26, 2024

概括

组合化疗,如T细胞淋巴瘤的CHOP,通常显示药物对抗性. 令人惊的是,同时使用可以最大限度地杀死瘤细胞,即使有敌对相互作用,这也挑战了之前的假设.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
数学生物学数学生物学

背景情况:

侵袭性淋巴瘤是用组合化疗治疗的,通常同时给予.
同时使用理论上是协同药物相互作用的最佳方案.
对外围T细胞淋巴瘤 (PTCL) 的标准CHOP疗法包括四种药物同时使用.

研究的目的:

在PTCL细胞系中研究CHOP疗法中的药理学相互作用.
为了确定分阶段的治疗计划是否可以改善瘤细胞的杀死,而不是同时给予.
使用剂量反应模型,将观察到的对抗性与最大化的瘤细胞杀死相协调.

主要方法:

在PTCL细胞系中研究了CHOP疗法的药理学相互作用.
利用体外模型来比较并发和分阶段的药物治疗计划.
调整了在放射治疗中常用的线性二次数 (LQ) 模型,以分析化疗剂量-反应关系和瘤异质性.

主要成果:

在PTCL细胞系中,CHOP疗法表现出一致的对抗性,而不是协同性.
同时服用药物最大限度地杀死瘤细胞,尽管观察到对抗性药物相互作用.
线性二次方程 (LQ) 模型解释了如何并发管理可以优越甚至与对抗,通过有利于累积DNA损伤.

结论:

同时的组合化疗可以最大限度地杀死瘤细胞,而不考虑药物相互作用的协同作用.
线性二次 (LQ) 模型为理解基于剂量反应动态的最佳化疗安排提供了一个框架.
这项研究揭示了组合化疗临床益处的新机制,独立于协同作用.

更多相关视频

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Combined Effects of Drugs: Antagonism

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...